Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 1Multiple Pulmonary Nodules 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Gastritis, Atrophic 1Desmoid Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Cancer Pain 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Multiple Advanced Tumors After PD-1 Therapy Failure × Radiofrequency Ablation × Clear all
NCT07095803 2025-07-31

Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure

Fudan University

Phase 2 Not yet recruiting
60 enrolled

Multiple Advanced Tumors After PD-1 Therapy Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡